Login

Insider Transactions

What FibroBiologics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 7
Sells 0 0
Total trades 0 7

Shares traded

3 months 12 months
Acquired 0 1,275
Disposed 0 0
Net activity +0 +1,275

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
O'heeron Pete CHIEF EXECUTIVE OFFICER Mar 04 Open-market buy · P +15,872 $0.38 +$6.01K 5,958,147
Khoja Hamid Chief Scientific Officer Mar 04 Open-market buy · P +30,000 $0.38 +$11.4K 61,250
O'heeron Pete CHIEF EXECUTIVE OFFICER Mar 03 Open-market buy · P +18,200 $0.41 +$7.37K 5,942,275
Davis Jason Chief Financial Officer Mar 02 Open-market buy · P +70,000 $0.41 +$29K 70,000
O'heeron Pete CHIEF EXECUTIVE OFFICER Mar 02 Open-market buy · P +17,428 $0.35 +$6.15K 5,924,075
Garcia Ruben A General Counsel Feb 27 Open-market buy · P +40,000 $0.33 +$13.1K 180,000
Garcia Ruben A General Counsel Dec 11 Open-market buy · P +140,000 $0.34 +$47.6K 140,000
Khoja Hamid Chief Scientific Officer May 27 Open-market buy · P +20,000 $0.84 +$16.8K 31,250
O'heeron Pete Chief Executive Officer Dec 09 Gift · G −100,000 5,906,647
O'heeron Pete Chief Executive Officer Dec 03 Gift · G −50,000 6,006,647
Khoja Hamid Chief Scientific Officer Aug 12 Open-market buy · P +10,000 $1.90 +$19K 11,250
O'heeron Pete Chief Executive Officer Aug 12 Open-market buy · P +8,500 $1.91 +$16.3K 6,056,647

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support